Sam Barone

Sam Barone

Company: Gemini Therapeutics

Job title: CMO


Spotlight on GEM103 – Restoring Physiologic Complement Activity with Complement Factor H (CFH) for GA 1:45 pm

Examine how Complement Factor H (CFH) dysfunction is evident in the pathogenesis of dry AMD Explore GEM103, a novel recombinant human CFH in clinical development for the treatment of dry AMD and GA Examine phase 2a data showing intravitreal GEM103 dosing results in sustained supraphysiological CFH in aqueous humor with functionality confirmed through reduction in…Read more

day: Track 2 Day 1 PM 1

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.